TrialAnnals of the rheumatic diseases2009

Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study.

M Rudwaleit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.